D Yao1, E Jakubowitz2, S Ettinger3, L Claassen3, C Plaass3, C Stukenborg-Colsman3, K Daniilidis3. 1. Department Fuß- und Sprunggelenkschirurgie, Orthopädie der Medizinischen Hochschule Hannover im DIAKOVERE Annastift, Anna-von-Borries-Straße 1-7, 30625, Hannover, Deutschland. daiwei.yao@diakovere.de. 2. Labor für Biomechanik und Biomaterialien, Orthopädischen Klinik der Medizinischen Hochschule Hannover, Hannover, Deutschland. 3. Department Fuß- und Sprunggelenkschirurgie, Orthopädie der Medizinischen Hochschule Hannover im DIAKOVERE Annastift, Anna-von-Borries-Straße 1-7, 30625, Hannover, Deutschland.
Abstract
INTRODUCTION: Neurologic paralysis of the foot due to damage to the central nervous system is primarily caused by a cerebral insult. The ankle-foot orthosis (AFO), which is the classical conservative treatment option, is associated with drawbacks, e.g., increased contractures, limited mobilization from the sitting position, and cosmetic aspects. METHODS: Functional external electrostimulation (FES) is an suitable treatment method for patients with a central lesion and intact peroneal nerve. Based on this method, the neuroprosthesis is a dynamic therapy option in the form of an implantable nerve stimulator (ActiGait® system, Otto Bock, Duderstadt, Germany) which is placed directly on the motor branch of the peroneus nerve and results in active foot lifting. The aim of the present study is to evaluate the clinical effect of the ActiGait® system with regard to its suitability for everyday use by means of gait tests with an emphasis on time-distance parameters and to compare it with the current literature. RESULTS AND CONCLUSION: In this retrospective study, the clinical results after implantation of the ActiGait® system are presented and evaluated. In summary, the implantation of a neuroprosthesis in patients with stroke-related drop foot represents a sensible and promising therapy option.
INTRODUCTION:Neurologic paralysis of the foot due to damage to the central nervous system is primarily caused by a cerebral insult. The ankle-foot orthosis (AFO), which is the classical conservative treatment option, is associated with drawbacks, e.g., increased contractures, limited mobilization from the sitting position, and cosmetic aspects. METHODS: Functional external electrostimulation (FES) is an suitable treatment method for patients with a central lesion and intact peroneal nerve. Based on this method, the neuroprosthesis is a dynamic therapy option in the form of an implantable nerve stimulator (ActiGait® system, Otto Bock, Duderstadt, Germany) which is placed directly on the motor branch of the peroneus nerve and results in active foot lifting. The aim of the present study is to evaluate the clinical effect of the ActiGait® system with regard to its suitability for everyday use by means of gait tests with an emphasis on time-distance parameters and to compare it with the current literature. RESULTS AND CONCLUSION: In this retrospective study, the clinical results after implantation of the ActiGait® system are presented and evaluated. In summary, the implantation of a neuroprosthesis in patients with stroke-related drop foot represents a sensible and promising therapy option.
Entities:
Keywords:
Functional electrostimulation; Neurologic drop foot; Neuroprosthesis; Paralysis foot; Stroke
Authors: Elaine L Miller; Laura Murray; Lorie Richards; Richard D Zorowitz; Tamilyn Bakas; Patricia Clark; Sandra A Billinger Journal: Stroke Date: 2010-09-02 Impact factor: 7.914
Authors: Klaus Daniel Martin; Witold Henryk Polanski; Anne-Kathrin Schulz; Michael Jöbges; Hansjoerg Hoff; Gabriele Schackert; Thomas Pinzer; Stephan B Sobottka Journal: J Neurosurg Date: 2015-07-24 Impact factor: 5.115
Authors: Jane H Burridge; Morten Haugland; Birgit Larsen; Ruth M Pickering; Niels Svaneborg; Helle K Iversen; P Brøgger Christensen; Jens Haase; Jannick Brennum; Thomas Sinkjaer Journal: J Rehabil Med Date: 2007-04 Impact factor: 2.912
Authors: D Yao; E Jakubowitz; S Ettinger; C Plaass; C Stukenborg-Colsman; K Daniilidis Journal: Oper Orthop Traumatol Date: 2017-05-04 Impact factor: 1.154